GROWTH AND FUNCTION OF A NOVEL BIO-ENGINEERED TRICUSPID VALVE IN A GROWING OVINE MODEL: RESULTS FROM A PRE-CLINICAL STUDY  by Zafar, Farhan et al.
Valvular Heart Disease
A2008
JACC April 1, 2014
Volume 63, Issue 12
growtH and functIon of a novel bIo-engIneered trIcusPId valve In a growIng ovIne 
model: results from a Pre-clInIcal study
Poster Contributions
Hall C
Sunday, March 30, 2014, 3:45 p.m.-4:30 p.m.
Session Title: Selected Topics in Valvular Therapy
Abstract Category: 29. Valvular Heart Disease: Therapy
Presentation Number: 1233-351
Authors: Farhan Zafar, Ryan Moore, Robert Hinton, Richard S. Baker, Roosevelt Bryant, Naritaka Kimura, Michael Taylor, David Morales, 
Cincinnati Children’s Hospital, Cincinnati, OH, USA
background: Valve replacement options in children lack the ability to grow with the patient and therefore require multiple reoperations. Small 
intestinal submucosa derived extracellular matrix (SIS-ECM) remodels into surrounding tissues and has been used successfully as a patch in a 
variety of tissues including artery and myocardium. A complete valve bioprosthesis made of SIS-ECM is hypothesized to remodel into native valve 
tissue and function and grow similar to a native valve. The objective of this study is to evaluate growth, structure and function of implanted SIS-ECM 
tricuspid valve (TV) in a growing ovine model.
methods: Nine lambs [median weight 18 (17-23) kg] are included; 7 with SIS-ECM TV placement and 2 age-matched controls with native valves 
(NV). Each lamb underwent echocardiogram at similar intervals to measure the valve annulus dimension valve and right ventricular (RV) function.
results: The SIS-ECM TV demonstrated physiologic growth as evidenced by an incremental increase in annular diameter similar to NV [3.0 vs 3.5 
mm; p = 0.5] [Figure 1]. All lambs (TV and NV) had stable trivial to mild regurgitation except one TV had moderate to severe regurgitation due to 
papillary detachment with a flail leaflet. All TV had full mobility without stenosis and RV systolic function was normal at follow-up.
conclusions: SIS-ECM TV bioprostheses demonstrate normal growth with preserved valve function at 3 months. The SIS-ECM may provide a unique 
solution for valve replacement in infants and small children.
 
